(Q28243807)

1

0 references

Kathryn J Swoboda

5

object named as

Kathryn J Swoboda

0 references

author name string

Jo Anne Maczulski

2

0 references

Thomas O Crawford

3

0 references

Charles Scott

Intraclass correlations: uses in assessing rater reliability

4

0 references

language of work or name

English

0 references

publication date

July 2006

0 references

published in

Neuromuscular Disorders

0 references

volume

16

0 references

issue

7

0 references

page(s)

417-26

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Natural history of denervation in SMA: relation to age, SMN2 copy number, and function

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Concerns about the design of clinical trials for spinal muscular atrophy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Review of the reliability and validity of myometry with children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

A placebo-controlled trial of gabapentin in spinal muscular atrophy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Arthritis hand function test: inter-rater reliability among self-trained raters.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

The process of rater training for observational instruments: implications for interrater reliability

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Construction and validation of the Alberta Infant Motor Scale (AIMS)

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Spinal muscular atrophy: survival pattern and functional status

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Motor function-muscle strength relationship in spinal muscular atrophy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Outcome measures for pediatric spinal muscular atrophy.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Reliability of hand-held dynamometry in spinal muscular atrophy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260054

Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy

27 November 2018

1 reference

12 December 2020

Clinical trial in Duchenne dystrophy. I. The design of the protocol

1 reference

12 December 2020

Interrater reliability: essential for research and practice

1 reference

12 December 2020

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone

1 reference

12 December 2020

Pragmatic aspects of establishing interrater reliability in research

1 reference

12 December 2020

Interrater reliability: the underdeveloped role of rater training

1 reference

12 December 2020

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy

1 reference

12 December 2020

Function changes in spinal muscular atrophy II and III. The DCN/SMA Group

1 reference

12 December 2020

Management of progressive muscular dystrophy in childhood

1 reference

12 December 2020

Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy

1 reference

12 December 2020

Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometry

1 reference

12 December 2020

The natural history of Duchenne muscular dystrophy: a caveat for therapeutic trials

1 reference

12 December 2020